Please use this identifier to cite or link to this item:
Title: Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'
Authors: Saad, E. D.
BUYSE, Marc 
Issue Date: 2016
Publisher: ELSEVIER
Source: ANNALS OF ONCOLOGY, 27(8), p. 1653
Abstract: 6. Yoon SH, Kim KW, Goo JM, Kim DW, Hahn S. Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer 2016; 53: 5-15. 7. Marten K, Auer F, Schmidt S et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur
Notes: [Saad, E. D.; Buyse, M.] Int Drug Dev Inst, Louvain La Neuve, Belgium. [Saad, E. D.] Dendrix Res, Sao Paulo, Brazil. [Buyse, M.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium.
Document URI:
ISSN: 0923-7534
e-ISSN: 1569-8041
DOI: 10.1093/annonc/mdw196
ISI #: 000383182800046
Rights: © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email:
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
  Restricted Access
Published version52.6 kBAdobe PDFView/Open    Request a copy
Show full item record

Page view(s)

checked on Sep 7, 2022


checked on Sep 7, 2022

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.